tiletamine hydrochloride has been researched along with Lymphoma, T-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horie, R; Umezawa, K; Watanabe, T | 1 |
1 review(s) available for tiletamine hydrochloride and Lymphoma, T-Cell
| Article | Year |
|---|---|
Blocking NF-kappaB as a potential strategy to treat adult T-cell leukemia/lymphoma.
Topics: Adult; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cyclohexanones; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T-Cell; NF-kappa B | 2006 |